Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Akshatha Ganne

Post Doctoral Fellow

Also affiliated: Central Arkansas Veterans Healthcare System (2022); Institute on Aging (2017–2024)

Postdoc Researcher

11 h-index 21 pubs 293 cited

  • Alzheimer Disease
  • Humans
  • Animals
  • Mice
  • Brain
  • Caenorhabditis elegans
  • Protein Aggregates
  • Male
  • Intrinsically Disordered Proteins
  • Peptide Chain Elongation, Translational
  • Endoplasmic Reticulum Chaperone BiP
  • Myocardial Infarction
  • Endoplasmic Reticulum Stress
  • Amyotrophic Lateral Sclerosis
  • Creutzfeldt-Jakob Syndrome

Biography and Research Information

OverviewAI-generated summary

Akshatha Ganne's research focuses on understanding the molecular mechanisms underlying neurodegenerative diseases, particularly Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS). Her work investigates the role of protein aggregates, intrinsically disordered proteins, and their interactions with nucleic acids in disease progression. Ganne has explored glial fibrillary acidic protein as a potential biomarker and therapeutic target for Alzheimer's disease. She has also examined the impact of protein aggregation on cellular stress, including myocardial infarction's effects on both heart and brain tissue. Her research utilizes computational analysis, such as machine learning, to identify factors contributing to neurodegeneration-related aggregation and in silico analysis to define disease mechanisms, as seen in her work on TUBA4A mutations in ALS. Ganne collaborates with researchers at the University of Arkansas for Medical Sciences, including Meenakshisundaram Balasubramaniam, Robert J. Shmookler Reis, and Srinivas Ayyadevara.

Metrics

  • h-index: 11
  • Publications: 21
  • Citations: 293

Selected Publications

  • Zolpidem restores sleep and decreases amyloid in a mouse model (2026)
    Alzheimer s & Dementia DOI OpenAlex
  • The aggregate proteome of Caenorhabditis elegans mitochondria implicates shared mechanisms of aging and Alzheimer’s disease (2026)
    Frontiers in Aging Neuroscience DOI OpenAlex
  • Zolpidem restores sleep and slows Alzheimer’s progression in a mouse model (2025)
    bioRxiv (Cold Spring Harbor Laboratory) 2 citations DOI OpenAlex
  • Ezetimibe Lowers Risk of Alzheimer’s and Related Dementias over Sevenfold, Reducing Aggregation in Model Systems by Inhibiting 14-3-3G::Hexokinase Interaction (2024)
    12 citations DOI OpenAlex
  • Rescue of ApoE4-related lysosomal autophagic failure in Alzheimer’s disease by targeted small molecules (2024)
    Communications Biology 21 citations DOI OpenAlex
  • Alzheimer’s-specific brain amyloid interactome: Neural-network analysis of intra-aggregate crosslinking identifies novel drug targets (2023)
    iScience 10 citations DOI OpenAlex
  • Myocardial infarction elevates endoplasmic reticulum stress and protein aggregation in heart as well as brain (2023)
    Molecular and Cellular Biochemistry 16 citations DOI OpenAlex
  • Protein homeostasis in the aged and diseased heart (2023)
    The Journal of Cardiovascular Aging 8 citations DOI OpenAlex
  • In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration (2023)
    Scientific Reports 14 citations DOI OpenAlex
  • Physiological Consequences of Targeting 14-3-3 and Its Interacting Partners in Neurodegenerative Diseases (2022)
    International Journal of Molecular Sciences 10 citations DOI OpenAlex
  • Machine-learning analysis of intrinsically disordered proteins identifies key factors that contribute to neurodegeneration-related aggregation (2022)
    Frontiers in Aging Neuroscience 14 citations DOI OpenAlex
  • Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease (2022)
    Pharmaceutics 45 citations DOI OpenAlex
  • In Silico Analysis of TUBA4A Mutations in Amyotrophic Lateral Sclerosis to Define Mechanisms of Microtubule Disintegration (2022)
    Research Square 1 citation DOI OpenAlex
  • Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer's Disease (2021)
    SSRN Electronic Journal 1 citation DOI OpenAlex
  • Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration (2021)
    Metabolic Brain Disease 35 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

33 Collaborators 15 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics